Current understanding and management of hidradenitis suppurativa.
OBJECTIVE
To review the diagnosis and treatment of hidradenitis suppurativa (HS) in primary care.


METHODS
Review of current literature from journals and textbooks as well as clinical experience.


CONCLUSIONS
HS, a chronic disease causing scarring and pus formation to the skin bearing apocrine glands, requires continual management by the primary care manager and often deems referral to a dermatologist or surgeon.


CONCLUSIONS
If misdiagnosed or poorly managed, HS has detrimental effects on patients' quality of life and self-esteem.
Krbec
Amanda C
AC
United States Air Force Academy, Colorado Springs, Colorado 80840, USA. amanda.krbec@usafa.af.mil
D000359:Aftercare; D000726:Androgen Antagonists / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D015984:Causality; D002908:Chronic Disease; D003937:Diagnosis, Differential; D004322:Drainage; D016903:Drug Monitoring; D017497:Hidradenitis Suppurativa / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use; D009722:Nurse Practitioners / Q000458:organization & administration*; D024802:Nurse's Role; D009730:Nursing Assessment; D010353:Patient Education as Topic; D011320:Primary Health Care / Q000379:methods*; D011379:Prognosis; D012008:Recurrence; D012017:Referral and Consultation; D012720:Severity of Illness Index; D017592:Skin Care / Q000379:methods / Q000451:nursing; D016896:Treatment Outcome
D000726:Androgen Antagonists; D000891:Anti-Infective Agents, Local; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007641:Keratolytic Agents